Detalles de la búsqueda
1.
Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing Enterobacterales.
Antimicrob Agents Chemother;
68(4): e0140423, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38411995
2.
Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run.
J Antimicrob Chemother;
79(1): 195-199, 2024 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019676
3.
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with "difficult to treat" Gram-negative bacteria.
Transpl Infect Dis;
26(2): e14238, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38265107
4.
Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis.
Crit Care;
28(1): 123, 2024 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38627763
5.
Linezolid Population Pharmacokinetics to Improve Dosing in Cardiosurgical Patients: Factoring a New Drug-Drug Interaction Pathway.
Clin Infect Dis;
76(7): 1173-1179, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36424854
6.
Population Pharmacokinetic and Pharmacodynamic Analysis of Valganciclovir for Optimizing Preemptive Therapy of Cytomegalovirus Infections in Kidney Transplant Recipients.
Antimicrob Agents Chemother;
67(3): e0166522, 2023 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815856
7.
Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections.
Antimicrob Agents Chemother;
65(5)2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33649108
8.
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?
Antimicrob Agents Chemother;
67(11): e0096923, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843260
9.
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction.
Antimicrob Agents Chemother;
65(5)2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33619055
10.
Clinical efficacy of renal dosing adjustments of ceftazidime-avibactam in patients affected by carbapenem-resistant Gram-negative infections: A systematic review and meta-analysis of observational studies.
Br J Clin Pharmacol;
89(2): 617-629, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36337045
11.
Successful and Safe Real-Time TDM-Guided Treatment of Invasive Pulmonary and Cerebral Aspergillosis Using Low-Dose Isavuconazole in a Patient with Primary Biliary Cirrhosis: Grand Round/A Case Study.
Ther Drug Monit;
45(2): 140-142, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728593
12.
Fast and Sensitive Analysis of Fosfomycin in Human Plasma Microsamples Using Liquid Chromatography-Tandem Mass Spectrometry for Therapeutic Drug Monitoring.
Ther Drug Monit;
2023 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38018880
13.
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?
Transpl Infect Dis;
25(5): e14107, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37515787
14.
Real-World Comparison of Isavuconazole and Voriconazole in Terms of the Need for Dosage Adjustments Guided by Clinical Pharmacological Advice During Primary Prophylaxis of Invasive Fungal Infections in Pediatric Patients with Hemato-Oncological Malignancies.
Ther Drug Monit;
44(5): 641-650, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35344524
15.
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients.
Crit Care;
26(1): 178, 2022 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701812
16.
The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison.
J Thromb Thrombolysis;
54(4): 593-596, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094687
17.
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections.
Curr Opin Infect Dis;
34(6): 737-747, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261906
18.
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis.
Mycoses;
64(11): 1317-1327, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387004
19.
Real-time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: results from a prospective, monocentric, interventional study.
J Antimicrob Chemother;
75(10): 3029-3037, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32681168
20.
Real-Time Therapeutic Drug Monitoring-Based Pharmacokinetic/Pharmacodynamic Optimization of Complex Antimicrobial Therapy in a Critically Ill Morbidly Obese Patient. Grand Round/A Case Study.
Ther Drug Monit;
42(3): 349-352, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32039939